Carvedilol
Brand name: Carvedilol
Rank #193 of 500 drugs by total cost
$75.6M
Total Cost
6,390,691
Total Claims
$75.6M
Total Cost
99,083
Prescribers
$12
Cost per Claim
1,656,767
Beneficiaries
14,315,476
30-Day Fills
$763
Avg Cost/Provider
64
Avg Claims/Provider
About Carvedilol
Carvedilol (sold as Carvedilol) was prescribed 6,390,691 times by 99,083 Medicare Part D providers in 2023, costing the program $75.6M. At $12 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 190 | Pravastatin Sodium (Pravastatin Sodium) | $76.8M | 4,033,829 |
| 191 | Lanadelumab-Flyo (Takhzyro) | $76.5M | 1,670 |
| 192 | Diltiazem Hcl (Diltiazem 24hr Er (Cd)) | $75.9M | 1,846,124 |
| 193 | Carvedilol (Carvedilol) | $75.6M | 6,390,691 |
| 194 | Cannabidiol (Cbd) (Epidiolex) | $75.5M | 15,726 |
| 195 | Eculizumab (Soliris) | $74.6M | 1,794 |
| 196 | Lidocaine (Lidocaine) | $74.4M | 416,864 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology